The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.

The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease. Contemp Clin Trials. 2019 04; 79:98-103.

View in: PubMed

subject areas

Adolescent
Child
Child, Preschool
Clinical Trials, Phase III as Topic
Comparative Effectiveness Research
Cross-Over Studies
Drug Resistance
Echocardiography
Female
Fever
Humans
Immunoglobulins, Intravenous
Infant
Inflammation Mediators
Infliximab
Length of Stay
Male
Mucocutaneous Lymph Node Syndrome
Multicenter Studies as Topic
Randomized Controlled Trials as Topic

authors with profiles

Allison H. Bartlett